Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1995 2
1996 2
1997 1
1999 1
2001 3
2004 3
2005 1
2006 1
2007 2
2008 4
2009 2
2010 4
2011 2
2012 1
2014 1
2015 1
2016 1
2017 1
2018 2
2019 5
2020 2
2021 2
2022 2
2023 6
2024 8
2025 4
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean m thomaidou d (4 results)?
Corrigendum to "Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK-positive advanced non-small cell lung cancer" [Lung Cancer 195 (2024) 107919].
Bauman JR, Liu G, Preeshagul I, Liu SV, Melosky B, Abrahami D, Li B, Thomaidou D, Duncan K, Krulewicz S, Rupp M, Lin JJ. Bauman JR, et al. Among authors: thomaidou d. Lung Cancer. 2025 Mar;201:108441. doi: 10.1016/j.lungcan.2025.108441. Epub 2025 Feb 23. Lung Cancer. 2025. PMID: 39988487 No abstract available.
Corrigendum to "Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK -positive advanced non-small cell lung cancer" [Lung Cancer 195 (2024) 107919].
Bauman JR, Liu G, Preeshagul I, Liu SV, Melosky B, Abrahami D, Li B, Thomaidou D, Duncan K, Krulewicz S, Rupp M, Lin JJ. Bauman JR, et al. Among authors: thomaidou d. Lung Cancer. 2024 Nov;197:108000. doi: 10.1016/j.lungcan.2024.108000. Epub 2024 Nov 2. Lung Cancer. 2024. PMID: 39488462 Free article. No abstract available.
Systematic review and network meta-analysis of lorlatinib with comparison to other anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs) as first-line treatment for ALK-positive advanced non-smallcell lung cancer (NSCLC).
Ou SH, Kilvert H, Candlish J, Lee B, Polli A, Thomaidou D, Le H. Ou SH, et al. Among authors: thomaidou d. Lung Cancer. 2024 Nov;197:107968. doi: 10.1016/j.lungcan.2024.107968. Epub 2024 Sep 29. Lung Cancer. 2024. PMID: 39368244 Free article.
Plain language summary: 5-year results from the CROWN study of lorlatinib vs crizotinib in non-small-cell lung cancer.
Solomon BJ, Liu G, Felip E, K Mok TS, Soo RA, Mazieres J, Shaw AT, Marinis F, Goto Y, Wu YL, Kim DW, Martini JF, Messina R, Paolini J, Polli A, Thomaidou D, Toffalorio F, Bauer TM. Solomon BJ, et al. Among authors: thomaidou d. Future Oncol. 2024 Dec;20(40):3377-3387. doi: 10.1080/14796694.2024.2406117. Epub 2024 Oct 3. Future Oncol. 2024. PMID: 39360949 Free PMC article.
Comparative Efficacy and Safety of Lorlatinib Versus Alectinib and Lorlatinib Versus Brigatinib for ALK-Positive Advanced/Metastatic NSCLC: Matching-Adjusted Indirect Comparisons.
Garcia C, Abrahami D, Polli A, Chu H, Chandler C, Tan M, Kelton JM, Thomaidou D, Bauer T. Garcia C, et al. Among authors: thomaidou d. Clin Lung Cancer. 2024 Nov;25(7):634-642. doi: 10.1016/j.cllc.2024.08.003. Epub 2024 Aug 13. Clin Lung Cancer. 2024. PMID: 39232917 Free article. Clinical Trial.
Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK-positive advanced non-small cell lung cancer.
Bauman JR, Liu G, Preeshagul I, Liu SV, Melosky B, Abrahami D, Li B, Thomaidou D, Duncan K, Krulewicz S, Rupp M, Lin JJ. Bauman JR, et al. Among authors: thomaidou d. Lung Cancer. 2024 Sep;195:107919. doi: 10.1016/j.lungcan.2024.107919. Epub 2024 Aug 3. Lung Cancer. 2024. PMID: 39197358 Free PMC article.
61 results